Cargando…

Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression

BACKGROUND: Major Depressive Disorder (MDD) is a prevalent, disruptive illness. A majority of those with MDD are at high risk for recurrence and increased risk for morbidity and mortality. This study examined whether multimodal baseline (and retest) Cognitive Control performance and neuroimaging mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Langenecker, Scott A., Jenkins, Lisanne M., Stange, Jonathan P., Chang, Yi-Shin, DelDonno, Sophie R., Bessette, Katie L., Passarotti, Alessandra M., Bhaumik, Runa, Ajilore, Olusola, Jacobs, Rachel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197328/
https://www.ncbi.nlm.nih.gov/pubmed/30321791
http://dx.doi.org/10.1016/j.nicl.2018.10.004
_version_ 1783364743480737792
author Langenecker, Scott A.
Jenkins, Lisanne M.
Stange, Jonathan P.
Chang, Yi-Shin
DelDonno, Sophie R.
Bessette, Katie L.
Passarotti, Alessandra M.
Bhaumik, Runa
Ajilore, Olusola
Jacobs, Rachel H.
author_facet Langenecker, Scott A.
Jenkins, Lisanne M.
Stange, Jonathan P.
Chang, Yi-Shin
DelDonno, Sophie R.
Bessette, Katie L.
Passarotti, Alessandra M.
Bhaumik, Runa
Ajilore, Olusola
Jacobs, Rachel H.
author_sort Langenecker, Scott A.
collection PubMed
description BACKGROUND: Major Depressive Disorder (MDD) is a prevalent, disruptive illness. A majority of those with MDD are at high risk for recurrence and increased risk for morbidity and mortality. This study examined whether multimodal baseline (and retest) Cognitive Control performance and neuroimaging markers (task activation and neural connectivity between key brain nodes) could differentiate between those with and without future recurrence of a major depressive (MD) episode within one year. We hypothesized that performance and neuroimaging measures of Cognitive Control would identify markers that differ between these two groups. METHODS: A prospective cohort study of young adults (ages 18–23) with history (h) of early-onset MDD (N = 60), now remitted, and healthy young adults (N = 49). Baseline Cognitive Control measures of performance, task fMRI and resting state connectivity (and reliability retest 4–12 weeks later) were used to compare those with future recurrence of MDD (N = 21) relative to those without future recurrence of MDD (N = 34 with resilience). The measures tested were (1) Parametric Go/No-Go (PGNG) performance, and task activation for (2) PGNG Correct Rejections, (3) PGNG Commission errors, and (4 & 5), resting state connectivity analyses of Cognitive Control Network to and from subgenual anterior cingulate. RESULTS: Relative to other groups at baseline, the group with MDD Recurrence had less bilateral middle frontal gyrus activation during commission errors. MDD Recurrence exhibited greater connectivity of right middle frontal gyrus to subgenual anterior cingulate (SGAC). SGAC connectivity was also elevated in this group to numerous regions in the Cognitive Control Network. Moderate to strong ICCs were present from test to retest, and highest for rs-fMRI markers. There were modest, significant correlations between task, connectivity and behavioral markers that distinguished between groups. CONCLUSION: Markers of Cognitive Control function could identify those with early course MD who are at risk for depression recurrence. Those at high risk for recurrence would benefit from maintenance or preventative treatments. Future studies could test and validate these markers as potential predictors, accounting for sample selection and bias in feature detection.
format Online
Article
Text
id pubmed-6197328
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61973282018-10-24 Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression Langenecker, Scott A. Jenkins, Lisanne M. Stange, Jonathan P. Chang, Yi-Shin DelDonno, Sophie R. Bessette, Katie L. Passarotti, Alessandra M. Bhaumik, Runa Ajilore, Olusola Jacobs, Rachel H. Neuroimage Clin Regular Article BACKGROUND: Major Depressive Disorder (MDD) is a prevalent, disruptive illness. A majority of those with MDD are at high risk for recurrence and increased risk for morbidity and mortality. This study examined whether multimodal baseline (and retest) Cognitive Control performance and neuroimaging markers (task activation and neural connectivity between key brain nodes) could differentiate between those with and without future recurrence of a major depressive (MD) episode within one year. We hypothesized that performance and neuroimaging measures of Cognitive Control would identify markers that differ between these two groups. METHODS: A prospective cohort study of young adults (ages 18–23) with history (h) of early-onset MDD (N = 60), now remitted, and healthy young adults (N = 49). Baseline Cognitive Control measures of performance, task fMRI and resting state connectivity (and reliability retest 4–12 weeks later) were used to compare those with future recurrence of MDD (N = 21) relative to those without future recurrence of MDD (N = 34 with resilience). The measures tested were (1) Parametric Go/No-Go (PGNG) performance, and task activation for (2) PGNG Correct Rejections, (3) PGNG Commission errors, and (4 & 5), resting state connectivity analyses of Cognitive Control Network to and from subgenual anterior cingulate. RESULTS: Relative to other groups at baseline, the group with MDD Recurrence had less bilateral middle frontal gyrus activation during commission errors. MDD Recurrence exhibited greater connectivity of right middle frontal gyrus to subgenual anterior cingulate (SGAC). SGAC connectivity was also elevated in this group to numerous regions in the Cognitive Control Network. Moderate to strong ICCs were present from test to retest, and highest for rs-fMRI markers. There were modest, significant correlations between task, connectivity and behavioral markers that distinguished between groups. CONCLUSION: Markers of Cognitive Control function could identify those with early course MD who are at risk for depression recurrence. Those at high risk for recurrence would benefit from maintenance or preventative treatments. Future studies could test and validate these markers as potential predictors, accounting for sample selection and bias in feature detection. Elsevier 2018-10-04 /pmc/articles/PMC6197328/ /pubmed/30321791 http://dx.doi.org/10.1016/j.nicl.2018.10.004 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Langenecker, Scott A.
Jenkins, Lisanne M.
Stange, Jonathan P.
Chang, Yi-Shin
DelDonno, Sophie R.
Bessette, Katie L.
Passarotti, Alessandra M.
Bhaumik, Runa
Ajilore, Olusola
Jacobs, Rachel H.
Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression
title Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression
title_full Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression
title_fullStr Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression
title_full_unstemmed Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression
title_short Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression
title_sort cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197328/
https://www.ncbi.nlm.nih.gov/pubmed/30321791
http://dx.doi.org/10.1016/j.nicl.2018.10.004
work_keys_str_mv AT langeneckerscotta cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT jenkinslisannem cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT stangejonathanp cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT changyishin cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT deldonnosophier cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT bessettekatiel cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT passarottialessandram cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT bhaumikruna cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT ajiloreolusola cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression
AT jacobsrachelh cognitivecontrolneuroimagingmeasuresdifferentiatebetweenthosewithandwithoutfuturerecurrenceofdepression